A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer

British Journal of Cancer, Published online: 20 September 2023; doi:10.1038/s41416-023-02431-7A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer

Source: British Journal of Cancer - September 20, 2023 Category: Cancer & Oncology Authors: Daphne Day John J. Park Jermaine Coward Ben Markman Charlotte Lemech James C. Kuo Amy Prawira Michael P. Brown Sarwan Bishnoi Dusan Kotasek R. Matthew Strother Rasha Cosman Rila Su Yiding Ma Zenglian Yue Hui-han Hu Rachel Wu Peiqi Li Archie N. Tse Source Type: research